Drugs / BIC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03472326 Background | Apr 2018 → Dec 2019 | HIV infectious disease | Gilead Sciences | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03472326 ↗ |
| Route | Oral | “Tablet(s) administered orally once daily” NCT03472326 ↗ |